A delivery platform for nucleic acids, enabling applications like vaccines, therapeutic protein production, and gene editing, and is the technology behind the first approved systemic RNA-LNP product.

A system for delivering small interfering RNA (siRNA) to target proteins involved in diseases, using ligands with high selectivity and binding affinity.